Posts

Vaccines and immunization: Vaccine safety

Image
Vaccination is one of the best ways to prevent illness. Overall, the vaccine is estimated to save 2 to 3 million lives each year. Together with the government, vaccine manufacturers, scientists, and medical professionals, the WHO Vaccine Safety Program continues to support vaccine safety monitoring. This helps ensure that the vaccine is safe for you and your family. The most commonly used vaccines today have been in use for decades, with millions of people safely receiving the vaccine each year. Several new vaccines are also under development. Once approved, they should help prevent other life-threatening illnesses such as Zika virus and Nipah virus, and improve the effectiveness of existing vaccines. Like all medicines, all vaccines must undergo extensive and rigorous testing before being introduced into the country. After use, it should be continuously monitored to ensure it is safe for the people who receive it. Vaccines are very safe. As with all medicines, side effects can occur

Anti-spikes receptor binding domain (RBD) levels and short-term adverse event dynamics after heterologous booster administration of BNT162b2 after two doses of CoronaVac

Image
CoronaVac was administered in early 2021 as the primary COVID19 vaccine for Thai healthcare professionals (HCWs) in response to a new variant epidemic. The purpose of this study is to evaluate the dynamics of the humoral immune response and the short-term side effects resulting from the additional administration of BNT162b2 after the completion of two doses of CoronaVac in Thai healthcare professionals. This study was conducted in August and September 2021 at a teaching hospital in northern Thailand. Participants were 50 healthcare workers vaccinated with two doses of CoronaVac and were expected to receive an additional dose of BNT162b2. We evaluated AntiSARSCoV2 IgG antibody levels and short-term side effects. Anti-RBD levels were determined using Architect SARSCoV2 IgG II Quant (Abbott). Of the 50 participants, 37 were women. The average age was 33.0 years. The average time between the second CoronaVac vaccination and the BNT162b2 booster was 81.7 days (SD = 25.0). Median anti-SARSCo

Localization of vaccination services: qualitative insights into public health and minority groups working together to encode coronavirus vaccines

Image
Minority and religious minorities are imbalanced in the effects of the SARSCoV2 pandemic and are less likely to accept coronavirus vaccination. In the orthodox Jewish quarter of the United Kingdom, the incidence of SARSCoV2 and measles increased from 2020 to 21 due to the non-optimal range of childhood immunization (2018-19). The purpose of our study was to find out how the Corona Virus Vaccination Program (CVP) works between public health services and orthodox Jewish medical institutions. The method included public health professionals, local community happiness and religious representatives, and 28 semi-shot interviews actually conducted by a religious representative and budget member. We examined CVP delivery from the perspective of people involved in the organization of service and vaccine's beneficiary. Interview data has been incorporated within the CVP's circulation of the Orthodian Jewish pressure and social media CVP. Analysis by theme is Prior to immunization with pub

Non-specific effects of veterinary vaccines

Image
The benefits of vaccines focus on specific effects on subsequent infections by target pathogens. However, recent studies have opened new insights into the additional effects of vaccines known as non-specific effects (NSEs) or heterologous effects of vaccines. Although several articles have reviewed the epidemiological and immunological evidence of NSE from human vaccines, there are few similar studies on veterinary vaccines. The purpose of this paper was to review the results of published studies on NSE from vaccines designed or reused for use in animals. As of April 30, 2021, a total of 8412 titles were retrieved from the PubMed and CABI databases. After the final stage of screening, 45 eligible articles were included in the review. The data in these articles are summarized and presented here. In general, most of the vaccines reviewed in the reviewed articles have beneficial NSEs for multiple pathogens and medical conditions. However, few studies report harmful NSEs from both non-live

Adherence to the vegetable-fruit-soy diet pattern, which is a reference from the Mediterranean diet, protects Chinese women from postmenopausal breast cancer

Image
The diet center hypothesis has gained much support from the apparent protective effect of the Mediterranean diet against breast cancer. However, evidence linking adherence to the Mediterranean diet to molecular subtypes of breast cancer remains inadequate, especially among non-Mediterranean populations. Method: The subject of the Wuxi exposure and breast cancer study in China is a population-based case-control study that includes 818 patients and 935 healthy controls. A modified version of the Validated Dietary Rating FFQ and Alternative Mediterranean Diet Score (aMED), the Alternative China Diet Score (aCHD) is to assess compliance with the migrated Chinese version of the Mediterranean diet called Vegetables-Fruits-Soybeans. A diet pattern developed in. Reflecting the region's cuisine, soy products, canola oil and coarse grains have replaced legumes, olive oil and whole grains. Vegetable-fruit-soybean stratified by menopausal state (pre-menopausal or post-menopausal) and receptor

Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children

Image
To determine the sturdiness of antibody patience after substitution of the MPCV vaccine for the MPSV-A vaccine in youngsters , an observational observe changed into performed in youngsters who voluntarily acquired doses of MPCV-AC rather than MPSV-A between March 2017 and March 2018 in Guangzhou, China. In total, 131 and forty-seven contributors had been enrolled withinside the 3-year- antique and 6-year- antique groups, respectively. In the 3-year- antique institution , the seroprotection price and GMT values for Men A and Men C had been raised notably after 1-month post-dose 1 MPSV booster vaccination. All immune signs had been notably decreasing in pre-dose 1 MPSV booster vaccination withinside the 3-year- antique institution than after pre-dose 2 MPSV booster vaccination withinside the 6-year- antique institution . While no tremendous variations had been discovered in maximum immune signs among the 1-month post-dose 1 MPSV booster vaccination wit

Knockout of Factor-Inhibiting HIF (Hif1an) in Colon Epithelium Attenuates Chronic Colitis but Does Not Reduce Colorectal Cancer in Mice

Image
Inflammatory bowel disease, such as chronic colitis, promotes colorectal cancer, the leading cause of cancer death worldwide. Hypoxia is   characteristic of inflammation and solid tumors and forces a gene expression response controlled by hypoxia-inducible factor (HIF). Once established, solid tumors are immunosuppressive and avoid attack by immune cells.   HIF activity is known to 1) promote the development of cancer   and 2) promote the suppression of tumor immunity through the secretion of adenosine, but procollagen-hydroxylase and asparagi called factor-inhibiting HIF (FIH). Both nylhydroxylase negatively regulate HIF. Therefore, FIH can act as a tumor suppressor in the development of colorectal cancer. This study investigated the role of colonic epithelial FIH in a mouse model of colitis-induced colorectal cancer. A Vil1Cre / FIH + f / + f and wild-type siblings of azoxymethane/dextran sulfate model were used to recreate the development of colitis-related colon cancer in mice. Col